Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People
ConditionDrug Use
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age75+
SponsorUmeå University
About this trial
This randomized controlled trial primarily investigates if a clinical pharmacist intervention can reduce drug-related readmissions among patients \>75 years. The intervention targets the transfer between hospital and primary care. In brief, the intervention includes medical chart reviews and patient interviews during a period of 180 days.
Eligibility criteria
Qualifiers
Living at home
Acutely admitted
Registered at one of ten pre-specified primary care health centers
Disqualifiers
Patients unable to communicate or who do not speak Swedish
Patients scheduled for palliative care
Patients admitted due to intoxication by alcohol or drug (non prescription)
Trial design
Treatments tested in this trial
- Enhanced clinical pharmacist service
Treatment groups
700 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov